NASDAQ:ESTA Establishment Labs (ESTA) Stock Price, News & Analysis $68.19 +2.64 (+4.03%) As of 01:38 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Establishment Labs Stock (NASDAQ:ESTA) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Establishment Labs alerts:Sign Up Key Stats Today's Range$65.49▼$70.0050-Day Range$54.69▼$74.6352-Week Range$33.35▼$83.31Volume182,828 shsAverage Volume509,753 shsMarket Capitalization$2.01 billionP/E RatioN/ADividend YieldN/APrice Target$87.14Consensus RatingModerate Buy Company Overview Establishment Labs Holdings Inc. is a global medical technology company specializing in the design, development and manufacture of silicone gel breast implants for aesthetic and reconstructive surgery. The company’s proprietary portfolio is built around patient-focused safety, customization and innovation, offering solutions intended to enhance surgical outcomes and support clinical traceability. The company’s flagship products fall under the Motiva® brand, which includes a range of ergonomic and round breast implants featuring SilkSurface® texturing and an embedded Q Inside® Safety microtransponder for unique implant identification. In addition to its core breast implant offerings, Establishment Labs is actively advancing a pipeline of complementary aesthetic and regenerative technologies aimed at expanding its footprint in minimally invasive and soft-tissue restoration procedures. Founded in Costa Rica in 2004, Establishment Labs has grown into an international enterprise with manufacturing facilities in Central America and distribution in more than 70 markets across North America, Latin America, Europe and the Asia-Pacific region. The company further broadened its capital access through a special purpose acquisition merger, resulting in its listing on the Nasdaq exchange in mid-2020. Leadership is anchored by founder and Executive Chairman Mauricio Cárdenas, whose entrepreneurial vision has guided the company since inception, alongside Chief Executive Officer Juan José Chacón, who oversees global operations, strategy and continued product innovation.AI Generated. May Contain Errors. Read More Establishment Labs Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks69th Percentile Overall ScoreESTA MarketRank™: Establishment Labs scored higher than 69% of companies evaluated by MarketBeat, and ranked 239th out of 851 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.3 / 5Analyst RatingModerate Buy Consensus RatingEstablishment Labs has received a consensus rating of Moderate Buy. The company's average rating score is 2.63, and is based on no strong buy ratings, 6 buy ratings, 1 hold rating, and 1 sell rating.Upside PotentialEstablishment Labs has a consensus price target of $87.14, representing about 28.4% upside from its current price of $67.88.Amount of Analyst CoverageEstablishment Labs has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Establishment Labs' stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Establishment Labs are expected to grow in the coming year, from ($1.07) to $0.14 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Establishment Labs is -45.32, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Establishment Labs is -45.32, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioEstablishment Labs has a P/B Ratio of 135.75. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Establishment Labs' valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted14.28% of the float of Establishment Labs has been sold short.Short Interest Ratio / Days to CoverEstablishment Labs has a short interest ratio ("days to cover") of 8.44.Change versus previous monthShort interest in Establishment Labs has recently decreased by 17.47%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldEstablishment Labs does not currently pay a dividend.Dividend GrowthEstablishment Labs does not have a long track record of dividend growth. News and Social Media2.0 / 5News Sentiment0.19 News SentimentEstablishment Labs has a news sentiment score of 0.19. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.39 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 5 news articles for Establishment Labs this week, compared to 3 articles on an average week.Search InterestOnly 1 people have searched for ESTA on MarketBeat in the last 30 days. This is a decrease of -67% compared to the previous 30 days. Company Ownership1.8 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Establishment Labs insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $22,854,538.00 in company stock.Percentage Held by Insiders9.99% of the stock of Establishment Labs is held by insiders.Percentage Held by Institutions72.91% of the stock of Establishment Labs is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Establishment Labs' insider trading history. Receive ESTA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Establishment Labs and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ESTA Stock News HeadlinesEstablishment Labs Holdings Inc. (NASDAQ:ESTA) Receives Consensus Rating of "Moderate Buy" from BrokeragesMay 19 at 2:07 AM | americanbankingnews.comRoute 92 Medical Announces Appointment of Raj Denhoy as Chief Financial OfficerMay 18 at 8:00 AM | globenewswire.comI was right about SpaceXJeff Brown predicted Bitcoin before it climbed as high as 52,400%, Tesla before 2,150%, and Nvidia before 32,000%. Now he says SpaceX is shaping up to be the biggest IPO of the decade - and three key milestones just confirmed it. In the past 21 days: SpaceX crossed 10,000 active satellites, Elon filed confidential IPO paperwork with the SEC, and another rocket launched 25 more satellites. Two-thirds of every satellite in orbit now belongs to one company. The public filing could drop any day.May 20 at 1:00 AM | Brownstone Research (Ad)Establishment Labs Holdings Inc ESTAMay 17 at 12:24 PM | morningstar.comMChacon Quiros sells Establishment Labs (ESTA) shares worth $214kMay 17 at 12:24 PM | investing.comContrasting Solventum (NYSE:SOLV) & Establishment Labs (NASDAQ:ESTA)May 16, 2026 | americanbankingnews.comEstablishment Labs (NASDAQ:ESTA) Director Sells $546,290.48 in StockMay 5, 2026 | insidertrades.comEstablishment Labs (NASDAQ:ESTA) Director Quiros Juan Jose Chacon Sells 2,180 SharesApril 28, 2026 | insidertrades.comSee More Headlines ESTA Stock Analysis - Frequently Asked Questions How have ESTA shares performed this year? Establishment Labs' stock was trading at $72.88 at the start of the year. Since then, ESTA stock has decreased by 6.9% and is now trading at $67.8760. How were Establishment Labs' earnings last quarter? Establishment Labs Holdings Inc. (NASDAQ:ESTA) announced its quarterly earnings results on Thursday, May, 7th. The company reported ($0.45) earnings per share for the quarter, missing analysts' consensus estimates of ($0.35) by $0.10. The business's quarterly revenue was up 44.7% on a year-over-year basis. Read the conference call transcript. When did Establishment Labs IPO? Establishment Labs (ESTA) raised $59 million in an initial public offering (IPO) on Thursday, July 19th 2018. The company issued 3,715,277 shares at $15.00-$17.00 per share. Jefferies and Cowen served as the underwriters for the IPO and BTIG was co-manager. Who are Establishment Labs' major shareholders? Establishment Labs' top institutional investors include Rice Hall James & Associates LLC (1.86%), Bank of America Corp DE (1.42%), First Light Asset Management LLC (1.05%) and ADAR1 Capital Management LLC (0.73%). Insiders that own company stock include Nicholas Sheridan Lewin, Quiros Juan Jose Chacon, Raj Denhoy and Raj Denhoy. View institutional ownership trends. How do I buy shares of Establishment Labs? Shares of ESTA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Establishment Labs own? Based on aggregate information from My MarketBeat watchlists, some other companies that Establishment Labs investors own include PayPal (PYPL), NVIDIA (NVDA), Walt Disney (DIS), Meta Platforms (META), Tesla (TSLA), Advanced Micro Devices (AMD) and Intel (INTC). Company Calendar Last Earnings5/07/2026Today5/20/2026AGM 20265/22/2026Next Earnings (Estimated)8/06/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (1m+) 1-Year History May 25 Aug 25 Nov 25 Feb 26 May 26 ESTA's financial health is in the Green zone, according to TradeSmith. ESTA has been in this zone for over one month. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Medical Services Sub-IndustryMedical Equipment Current SymbolNASDAQ:ESTA CIK1688757 Webwww.establishmentlabs.com Phone(062) 434-2400FaxN/AEmployees1,004Year Founded2004Price Target and Rating Average Price Target for Establishment Labs$87.14 High Price Target$100.00 Low Price Target$74.00 Potential Upside/Downside+28.1%Consensus RatingModerate Buy Rating Score (0-4)2.63 Research Coverage8 Analysts Profitability EPS (Trailing Twelve Months)($1.49) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$51.06 million Net Margins-19.05% Pretax Margin-22.35% Return on Equity-218.77% Return on Assets-12.31% Debt Debt-to-Equity Ratio16.82 Current Ratio2.96 Quick Ratio1.91 Sales & Book Value Annual Sales$211.08 million Price / Sales9.49 Cash FlowN/A Price / Cash FlowN/A Book Value$0.50 per share Price / Book136.07Miscellaneous Outstanding Shares29,430,000Free Float26,490,000Market Cap$2.00 billion OptionableOptionable Beta1.12 Social Links Reduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link to learn more about using beta to protect your portfolio.Get This Free Report This page (NASDAQ:ESTA) was last updated on 5/20/2026 by MarketBeat.com Staff. From Our PartnersNevada gold explorer near Kinross district draws attentionGold has surged past $5,300 per ounce, with Goldman Sachs and JPMorgan forecasting $6,000+ by end of 2026. Cen...Wall Street Logic | SponsoredThe Last Time This Market Moved, Early Investors Took NoticeLithium has already had one major run - and now prices are starting to move again. EV adoption and energy stor...i2i Marketing Group, LLC | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredIran's New Leader Just Said Something That Should Terrify Every AmericanIran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...American Alternative | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredI was right about SpaceXJeff Brown predicted Bitcoin before it climbed as high as 52,400%, Tesla before 2,150%, and Nvidia before 32,0...Brownstone Research | SponsoredIran War Update: Trump’s Hand-Written Letter Reveals What Comes NextJim Rickards has uncovered what he believes is Trump's economic plan, with a key trigger date of May 15. The F...Paradigm Press | SponsoredI’m sounding the alarmMeta is cutting 10% of its workforce. Microsoft offered voluntary retirement to 7% of U.S. employees. Oracle, ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Establishment Labs Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Establishment Labs With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
